US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
| CAS Number : | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2021-07-02T00:00:00
APL-2, pegcetacoplan (CAS # 2019171-69-6)
The subject product is APL-2, also referred to as pegcetacoplan (CAS # 2019171-69-6). The product is marketed for use in clinical trials to treat various immunological diseases. You state that the product targets the part of the immune system known as the complement system. The product is formed in a single reaction between Peptide 1603 and polyethylene glycol (PEG). You note that the pegylated product is preferred because the PEG extends the half-life of the compound, allowing the APL-2 drug product to be dosed less frequently and in smaller amounts. The product will be imported into the United States as a pure bulk solid.
Description : APL-2, pegcetacoplan
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :